Biotechnology Shareholder Alert – The M&A Class Action Firm Announces an Investigation of BioHaven Pharmaceutical Holding Company Ltd. – BHVN May 13, 2022
Biotechnology The Zacks Analyst Blog Highlights Regeneron, Vertex, Intercept Pharmaceuticals, and Biohaven Pharmaceutical May 13, 2022
Biotechnology BridgeBio Pharma Sells Rare Pediatric Disease Priority Review Voucher for $110 Million and Defers Principal Payment on Senior Debt by Two Years May 13, 2022
Biotechnology Editas Medicine Receives FDA Orphan Drug Designation for EDIT-301 for the Treatment of Beta Thalassemia May 12, 2022
Biotechnology Apellis Announces Seven Abstracts in PNH to be Presented at the European Hematology Association Congress May 12, 2022
Search
investing in biotech
